Changing incidence of non-Hodgkin lymphomas in the United States

被引:131
作者
Clarke, CA [1 ]
Glaser, SL [1 ]
机构
[1] No Calif Canc Ctr, Union City, CA 94587 USA
关键词
lymphoma; non-Hodgkin lymphoma; epidemiology; mortality; SEER Program; epidemiologic studies; incidence; child; adolescent; middle age; aged;
D O I
10.1002/cncr.10403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The incidence of non-Hodgkin lymphoma (NHL) has been rising in many regions and populations during the last few decades. Data from the Surveillance, Epidemiology, and End Results (SEER) Program show that age-adjusted rates of NHL increased through the 1980s but leveled off in the 1990s. METHODS. To determine whether the incidence of NHL stabilized in all population subgroups, particularly in age-defined groups with distinctive risks of NHL, the authors investigated trends in NHL incidence among persons aged 0-14 years, 15-24 years, 25-34 years, 35-44 years, 45-54 years, 55-64 years, 65-74 years, and > 75 years by gender and race using 1973-1998 data from the SEER Program, which covered approximately 10% of the U.S. population. Joinpoint regression was used to assess changes in trends across the period. RESULTS. NHL incidence trends changed significantly among males aged 25-54 years, in whom rates began to decrease (6-16% per year) in the middle to late 1990s, as well as among most whites aged greater than or equal to55 years, in whom rate increases slowed from 3-4% to 1-2% per year in the late 1980s. Incidence trends were steady in other groups, with uniform increases among whites aged 15-24 years (2-3% per year), women aged 25-54 years (1-6% per year), and blacks aged : 55 years (2-4% per year). Although recent age specific incidence rates were generally higher in males compared with females and in whites compared with blacks, among males aged 25-54 years, rates were significantly higher in black males compared with white males. CONCLUSIONS. There have been changes in the demographic groups impacted by NHL. The trends for human immunodeficiency virus probably are related to recent decreases in NHL incidence among males aged 25-54 years. The rate change in the older white population is unexplained but represents both an alleviation of the burden of NHL in this population and a potential opportunity to generate hypotheses regarding risk factors for the development of NHL.
引用
收藏
页码:2015 / 2023
页数:9
相关论文
共 50 条
  • [31] FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
    Barrington, Sally F.
    Kluge, Regine
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S97 - S110
  • [32] Gene Expression Profiling of Non-Hodgkin Lymphomas
    Zekri, Abdel-Rahman Nabawy
    Hassan, Zeinab Korany
    Bahnassy, Abeer Ahmed
    Eldahshan, Dina Hassan
    El-Rouby, Mahmoud Nour Eldin
    Kamel, Mahmoud Mohamed
    Hafez, Mohamed Mahmoud
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4393 - 4398
  • [33] Non-Hodgkin lymphomas of Waldeyer's ring
    Salplahta, D.
    Comanescu, Maria Victoria
    Anghelina, F.
    Ionita, Elena
    Mogoanta, Carmen Aurelia
    Anghelina, Liliana
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (04) : 1057 - 1060
  • [34] Infection-associated non-Hodgkin lymphomas
    Suarez, F.
    Lecuit, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (11) : 991 - 997
  • [35] Biomarkers of susceptibility to chemical carcinogens: the example of non-Hodgkin lymphomas
    Kelly, Rachel S.
    Vineis, Paolo
    BRITISH MEDICAL BULLETIN, 2014, 111 (01) : 89 - 100
  • [36] Non-Hodgkin's lymphomas in children.
    Bergeron, C
    Frappaz, D
    Philip, T
    ANNALES DE PEDIATRIE, 1998, 45 (04): : 246 - 255
  • [37] New therapeutic strategies in non-Hodgkin lymphomas and Hodgkin lymphoma
    Rossi, C.
    Bastie, J. N.
    REVUE DE MEDECINE INTERNE, 2019, 40 (04): : 246 - 254
  • [38] Diagnostics and staging of non-Hodgkin's lymphomas
    Neumann, S.
    Jung, W.
    Truemper, L.
    INTERNIST, 2007, 48 (04): : 362 - 371
  • [39] Improving the Efficacy of Radioimmunotherapy for Non-Hodgkin Lymphomas
    Palanca-Wessels, M. Corinna A.
    Press, Oliver W.
    CANCER, 2010, 116 (04) : 1126 - 1133
  • [40] New drugs for the treatment of non-Hodgkin lymphomas
    Smith, Sonali M.
    CHINESE CLINICAL ONCOLOGY, 2015, 4 (01)